Botox Flashcards
1
Q
When can general dentists use Botox?
A
- Botox & dermal fillers
- tx functional or aesthetic dental conditions
2
Q
Botulinum Toxin (BTX)
A
- Most potent neurotoxin
- natural
- Produced by Gram (+) anaerobic bacteria→Clostridium Botulinum
- 3 antigen subtypes
- A, B, C1, D, E, F, G, H
- Incubation Period:
- 18-36 hr after ingestion
- Heat Labile
- denatured by cooking
3
Q
How does Botulism occur?
A
- Ingest contaminated food
- Toxin → peripheral cholinergic nerves
- Blocks acetylcholine release
- Results:
- Bilateral symmetric descending neuroparalytic illness
4
Q
What types of Botulism occurs in humans vs animals?
A
- Humans:
- Types: A, B, E, F(rare)
- Animals:
- C & D
5
Q
Type A Botulinum Toxin
A
- most common for cosmetics
- 3 forms:
- Botox
- Dysport
- Xeomin
6
Q
Type B Botulinum Toxin
A
- 1 form
- MyBloc
7
Q
What does each vial of BOTOX contain?
A
- Clostridium botulinum Type A
- 100 units (U)
- Albumin Human
- 0.5 milligrams
- Sodium chloride
- 0.9 mg
8
Q
Botox MOA: (w/Botox & no Botox)
A
- BTXA inhibits release of acetylcholine (Ach)
- at neuromuscular junction
- Large Dose=complete paralysis
- Therapeutic Dose: Partial activity
- NO BOTOX:
- Ach released→ Muscle Contraction
9
Q
Botox Therapy: Systemic Side Effects
A
- Anxiety
- Dizziness, Drowsiness, headache, Dry mouth, Dry Eyes
- Pharyngitis
- dysphagia (difficulty swallowing)
- facial pain
- flu-like symptoms
- Can’t focus eyes
- drooping eyelid/eyebrow
- double/blurred vision
- Sensitive to light
- Indigestion
- Nausea
- Swearting
- Fever
- Chills
- Allergic rxn
- Rash
- itching
- Dyspnoe
- chest tightness
- face edema
- hoarse voice
- Respiratory infection
- anaphylaxis
- urticaria
- erythema multiforme
- No bladder control
- No Strength
- paralysis
- seizures
10
Q
Botox Therapy: Local Side Effects
A
- Muscle soreness
- Partial muscle weakness (temporary)
- Muscle Atrophy
- prolonged use of botox
- reversible if discontinued
- Redness
- tingling
- bruising
- swelling
- bleeding
11
Q
Botox: Contraindications
A
- Aminoglycoside antibiotics
- aspirin
- chloroquine
- calcium channel blockers
- quinine
- Pregnant or Nursing women
- Children
- Cardiovascular Disorders
- Neuromuscular disorders
- Myasthenia Gravis
- Impaired Hemostasis
- Pre-existing infection at injection site
- Skin Infections
- Eczema
- psoriasis
- 65+ -Emotional
- Botulinum hypersensitivity
12
Q
What are the uses of Botulinum toxin type A in Dentistry
A
- Bruxism
- Facial Nerve palsy/paresis
- Gummy Smile
- Headache
- Migraine
- Massetric Hypertorphy
- Mandibular Spasm
- Muscle retraining during Ortho
- Myofascial Pain
- Oromandibular Dystonia (OMD)
- oral surgery-Implants
- Salivary Gland Disorders
- Trigeminal Neuralgia
- Postherpetic Neuralgia
13
Q
Myofascial Pain
A
- Muscle Pain & tenderness
- Mastication Muscles
- Trigger point/Band Muscles
- Botox
- reduces hyperactivity
- temporary alleviate pain & dysfunction
- Results: Inconclusive (due to etiology)
- Myositis=cause of pain
- can’t treat w/Botox
- lacks anti-inflammatory
- not always muscle hyperactivity
- Myositis=cause of pain
- Results: Inconclusive (due to etiology)
14
Q
Bruxism
A
- Severe Bruxism
- inject masseter muscles
- Therapeutic response: 19 weeks
15
Q
Oromandibular Dystonia (OMD)
A
- movement disorder
- involuntary spasms & muscle contractions
- difficulty speaking, swallowing, and eating
- Forms: Muscle injected
- Jaw-Closure dystonia
- Bilateral Masseter muscles
- Jaw-Opening Dystonia
- Lateral pterygoids
- Lingual Dystonia
- Tongue muscles
- Jaw-Closure dystonia
- Recommended dose: 30 U per side
16
Q
Massetric Hypertrophy
A
- Enlarged masseter muscles
- Asymptomatic
- unilateral or bilateral
- Asymptomatic
- Inject Masseter Muscle
- 100 U of BTXA
17
Q
Mandibular Spasm
A
- Semicontracted or muscle spasms that close jaw
- Trismus→ Difficulty Eating
- Masseter M.
- 25 U
- Temporalis M
- 10 U
- Masseter M.
18
Q
Gummy Smile
A
- Excess gums
- due to hyper-fxnal upper lip muscles
- Nasalis
- orbicularis oculi
- levator labii superioris
- Levator labii superiors alaeque nasi
- levator anguli oris
- Zygomaticus major
- due to hyper-fxnal upper lip muscles
- Recommended Dose of BTX:
- Levator labii superiori & Zygomaticus→ 2.5 U
- Orbicularis Oculi → 1.25 U
19
Q
Dental Implants and Jaw/Oral Surgery
A
- Implant failure due to:
- No osseointegration
- Parafunctional habits
- Maxillofacial fractures (Zygomatic & Condylar)
- require hardware to overcome masticatory muscle forces: prevent callus formation
- Prophylactic injection: 100 U BTXA
- bilateral masseter muscle
- 12-48 before surgery
- Reduce forces
- Periodontal Surgery
- BTX reduce perio trauma due to excessive muscular function
20
Q
Headache and Migraine
A
- BTX
- Decrease muscle contraction by
- prevent ACh release from presynaptic terminal
- Inhibits neurotransmitter transmission at gamma motorneurons in muscle spindle
- decreases muscle activity
- Enter CNS and modulate pain by:
- inhibit release of substance P from trigeminal nerve endings
- Reduce parasympathetic outflow
- leads to analgesia
- Chronic Headaches
- Decrease muscle contraction by
- Doses of BTX:
- Headache and migraine:
- Range: 10-150 U
- Cluster Headache:
- 24- 150 U of BTXA or
- 1200 U BTXB
- Headache and migraine:
21
Q
Trigeminal & Postherpetic Neuralgia
A
- Trigimenal Neuralgia
- BTX:
- inhibits:
- exocytosis of ACh and other neurotransmitters
- release of NE and ATP from postganglionic sympathetic nerve endings:
- Analgesic effect
- Reduces central and peripheral sensitization
- inhibits:
- Dose: 20-50 U
- trigger zone or masseter m.
- BTX:
- Postherpetic neuralgia
- alternate tx modality
- Dose: 15 U intradermally
- inhibits release of:
- formalin-induced glutamate
- substance P
- CGRP
- direct effect: Sensory neurons
- Indirect effect: CNS
- Pain decreases to mild & tolerable levels in 1st week
- inhibits release of:
22
Q
Facial Nerve Palsy/paresis
A
- Paresis=Incomplete Loss of Facial N fxn
- Paralysis=complte loss
- Unilateral Palsy
- affects balance b/w R & L side of face
- Causes Asymmetry
- BTXA Dose: 10-80 U
- intra-muscular
- contralateral lower facial muscle
- weakens & restores facial symmetry
- Side effect: Drooling
23
Q
Salivary Gland Disorders
A
- BTX
- block cholinergic parasympathetic secretomotor fibers of salivary gland
- Tested in:
- sialorrhea
- Frey’s Syndrome
24
Q
Retraining Muscles during Ortho Treatment
A
- prevent relapse of ortho in patients w/stronger muscle activity
- mentalis m.
- Reduced intensity of muscle post treatment & overtime
- retrained to more physiologic movement